The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...
Back in 2024, the rise of generative AI took the spotlight in the market, with the discussion shifting to agents in 2025.
Tokenized venture capital for retail investors. Institutional deal flow, low minimums, real yield. Analysts tracking for ...
Financial crime compliance in U.S. banking and financial institutions is at an inflection point. For decades, institutions ...
TipRanks on MSN
Aptose reschedules special meeting on Hanmi acquisition plan
Aptose Biosciences ( ($TSE:APS) ) has issued an announcement. On December 19, 2025, Aptose Biosciences announced it would reschedule a special ...
Nordea Bank Abp downgraded to Hold as shares trade above fair value amid Nordic banking margin pressure and mortgage risk ...
This enforcement action is one part of a larger strategy that has been created by the Pakistan Virtual Assets Regulatory ...
Detailed price information for Senti Biosciences Inc (SNTI-Q) from The Globe and Mail including charting and trades.
Stocktwits on MSN
SLS stock breaches $5 level after over 3 years: Retail now eyes buyout for as much as $25B
SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid ...
Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.
As of Wednesday, December 24, TScan Therapeutics, Inc.’s TCRX share price has surged by 7.51%, which has investors questioning if this is right time to sell.
Doris Nkiruka Uzoka-Anite is having one of those rare political moments when preparation meets power. The Nigerian Minister ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results